Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2017 Jun 26;91(14):e00218-17. doi: 10.1128/JVI.00218-17

Immune Escape Variants of H9N2 Influenza Viruses Containing Deletions at the Hemagglutinin Receptor Binding Site Retain Fitness In Vivo and Display Enhanced Zoonotic Characteristics

Thomas P Peacock a,b, Donald J Benton c, Joe James a,b, Jean-Remy Sadeyen a, Pengxiang Chang a, Joshua E Sealy a,d, Juliet E Bryant e, Stephen R Martin c,f, Holly Shelton a, Wendy S Barclay b, Munir Iqbal a,
Editor: Adolfo García-Sastreg
PMCID: PMC5487547  PMID: 28468875

ABSTRACT

H9N2 avian influenza viruses are enzootic in poultry across Asia and North Africa, where they pose a threat to human health as both zoonotic agents and potential pandemic candidates. Poultry vaccination against H9N2 viruses has been employed in many regions; however, vaccine effectiveness is frequently compromised due to antigenic drift arising from amino acid substitutions in the major influenza virus antigen hemagglutinin (HA). Using selection with HA-specific monoclonal antibodies, we previously identified H9N2 antibody escape mutants that contained deletions of amino acids in the 220 loop of the HA receptor binding sites (RBSs). Here we analyzed the impact of these deletions on virus zoonotic infection characteristics and fitness. We demonstrated that mutant viruses with RBS deletions are able to escape polyclonal antiserum binding and are able to infect and be transmitted between chickens. We showed that the deletion mutants have increased binding to human-like receptors and greater replication in primary human airway cells; however, the mutant HAs also displayed reduced pH and thermal stability. In summary, we infer that variant influenza viruses with deletions in the 220 loop could arise in the field due to immune selection pressure; however, due to reduced HA stability, we conclude that these viruses are unlikely to be transmitted from human to human by the airborne route, a prerequisite for pandemic emergence. Our findings underscore the complex interplay between antigenic drift and viral fitness for avian influenza viruses as well as the challenges of predicting which viral variants may pose the greatest threats for zoonotic and pandemic emergence.

IMPORTANCE Avian influenza viruses, such as H9N2, cause disease in poultry as well as occasionally infecting humans and are therefore considered viruses with pandemic potential. Many countries have introduced vaccination of poultry to try to control the disease burden; however, influenza viruses are able to rapidly evolve to escape immune pressure in a process known as “antigenic drift.” Previously, we experimentally generated antigenic-drift variants in the laboratory, and here, we test our “drifted” viruses to assess their zoonotic infection characteristics and transmissibility in chickens. We found that the drifted viruses were able to infect and be transmitted between chickens and showed increased binding to human-like receptors. However, the drift mutant viruses displayed reduced stability, and we predict that they are unlikely to be transmitted from human to human and cause an influenza pandemic. These results demonstrate the complex relationship between antigenic drift and the potential of avian influenza viruses to infect humans.

KEYWORDS: avian influenza virus, H9N2, hemagglutinin, receptor binding site, zoonotic, pandemic, antigenic drift

INTRODUCTION

Avian influenza viruses (AIVs) pose a major threat to global food security, with emergent outbreaks causing billions of dollars of damage to affected countries (1). In addition to their economic impact on the poultry sector, AIVs also continue to pose a considerable threat to public health due to the emergence of zoonotic viruses with pandemic potential.

Low-pathogenicity avian influenza virus subtype H9N2 is one of the most widespread AIV subtypes in poultry. Despite the classification of H9N2 viruses as being of low pathogenicity, these viruses cause significant production losses in poultry in many countries throughout Asia, the Middle East, and North Africa (2, 3). In laboratory settings, H9N2 viruses typically exhibit low morbidity and mortality rates in chickens (4); however, H9N2 viruses have displayed flock mortality rates of up to 60% as well as moderately pathogenic phenotypes in laboratory settings (49). In recent years, an increasingly large number of human H9N2 infections have been identified in Hong Kong, Mainland China, Bangladesh, and Egypt, usually during surveillance for other zoonotic influenza virus infections such as H5N1, H5Nx, H7N9, and H10N8 (1013). A growing body of serological evidence suggests that asymptomatic or mild infections with H9N2 may be fairly common in enzootic areas, especially among poultry workers (14). Experimental infections with H9N2 viruses in ferrets have demonstrated that some strains can exhibit transmission via respiratory droplets, a property generally thought to be a prerequisite to becoming a human pandemic influenza virus (1520).

Classical inactivated vaccines have been widely utilized in poultry in many areas to attempt to curb economic losses associated with H9N2 infection (8, 2124). Veterinary influenza vaccines face challenges similar to those of human seasonal influenza vaccines in terms of requiring continual evaluation and updating due to virus antigenic drift. To date, there are limited field data assessing the efficacy of currently licensed H9N2 vaccines, and epidemiological studies suggest that enzootic transmission may continue even in regions with large numbers of vaccinated flocks (21, 22, 24).

Hemagglutinin (HA) is a homotrimeric transmembrane glycoprotein encoded by segment 4 of the influenza virus genome and plays a major role in virus adaption to new hosts, antigenicity, and pathogenesis. Each monomer of HA consists of two domains: (i) a head that contains the receptor binding site (RBS), vital for the binding of influenza viruses to their cognate receptors of terminal sialic acid (SA) residues on glycans of the host cell surface, and (ii) the stalk domain, which contains the fusion peptide involved in the pH-mediated fusion of the viral and host endosomal membranes, allowing the release of virus genetic material into the host cytoplasm. Both natural immunity and vaccine-induced immunity are mediated primarily through antibodies against HA, in particular neutralizing antibodies that block the receptor binding ability of HA (25). In response to immune pressure exerted by neutralizing antibodies, viruses are able to “escape” through the accumulation of amino acid substitutions or, more rarely observed, amino acid deletions (26, 27).

The HA RBS is comprised of three subdomains, the 130 loop, the 190 helix, and the 220 loop. Residues within the 220 loop and, to a lesser extent, the 190 helix have been shown to be major determinants of the binding preference for either “human-like” α2,6-linked SA or “avian-like” α2,3-linked SA. Furthermore, these determinants of binding preference appear to be conserved across multiple influenza virus subtypes (2831). Substitutions in amino acid residues that influence the preference for SA are well established as markers of augmented zoonotic and pandemic potential (32, 33).

In our previous study, we used a panel of monoclonal antibodies (MAbs) to select for H9N2 escape mutants of A/chicken/Pakistan/UDL-01/2008 (here referred to as UDL1/08). We demonstrated that a subset of these MAbs selected for mutant HA proteins that had deletions in the 220 loop regions of their RBSs, here collectively referred to as deletion mutants (34). Here we characterized the deletion mutants using a combination of in vitro, in vivo, and biochemical approaches to measure receptor binding avidity, replication kinetics, transmission potential in chickens, and HA stability. Our results help inform risk assessments of whether these viruses pose epizootic and zoonotic threats compared to contemporary H9N2 viruses found in poultry.

RESULTS

Deletion mutant viruses are poorly recognized by chicken and ferret antisera against homologous and heterologous H9N2 viruses.

We previously determined that all UDL1/08 viruses with loop deletions have greatly reduced hemagglutination inhibition (HI) activity against the selecting MAbs by >128-fold (34). To further evaluate the antigenic properties of these deletion mutants, we carried out HI and microneutralization (MNT) assays with a panel of 8 polyclonal chicken antisera raised against the wild-type (wt) UDL1/08 virus. All five deletion mutants exhibited a significant drop in their recognition by chicken polyclonal antisera, measured by both HI and MNT assays, compared to the wt virus (P ≤ 0.0001 by one-way analysis of variance [ANOVA] with multiple comparisons against the wt) (Fig. 1A and B and Table 1). The fold reductions in HI and MNT titers for the deletion mutant viruses compared to the wt UDL1/08 virus were between 2.3- and 3.6-fold and between 3.1- and 6.72-fold, respectively.

FIG 1.

FIG 1

Antigenic properties of five 220 loop deletion viruses. (A) HI assay with 8 individual chicken polyclonal postinfection antisera raised against wt UDL1/08. The y axis indicates the relative HI titer compared to the homologous titer of the antisera against wt UDL1/08, normalized to zero (dotted line). (B) MNTs with 6 individual chicken polyclonal postinfection antisera raised against wt UDL1/08. The y axis indicates the relative MNT titer compared to the homologous titer of the antisera against wt UDL1/08, normalized to zero (dotted line). (C) 220 loop deletion viruses tested by relative HI titers with 6 heterologous antisera raised against Em/R66. Antisera against UDL1/08 were normalized to zero (dotted line). Each colored dot represents a different antiserum. Black lines show mean changes in HI and standard error bars for each mutant virus. Significance was determined by one-way ANOVA with multiple comparisons against wt UDL1/08. *, 0.05 ≥ P > 0.01; **, 0.01 ≥ P > 0.001; ***, 0.001 ≥ P > 0.0001; ****, P ≤ 0.0001.

TABLE 1.

Antigenic properties of five 220 loop deletion virusesa

Postinfection antiserum Method Geometric mean titer of virus (HA/MNT units)
Wild-type UDL1/08 L206F/Δ207–212 Δ208–212 Δ208–213 Δ210–213 Δ211–215
8× UDL1/08 (chicken p.i.) HI 1,500 512**** 583**** 583**** 412**** 535****
MNT 570 76.1**** 114**** 170**** 128**** 148****
6× Em/R66 (chicken p.i.) HI 41.3 27.8**** 22.6**** 21.3**** 10.9**** 27.6****
1× BD/0994 (ferret p.i.) HI 1,280b 320 2,560 320 320 2,560
a

p.i., postinfection. **** indicates a P value of ≤0.0001, calculated by using one-way ANOVA with multiple comparisons against the wild-type titer.

b

Significance was unable to be determined due to a single antiserum only.

In a field setting, vaccine seed strains are rarely closely antigenically matched to circulating poultry viruses, thus posing a continuing challenge for evaluating the efficacy of vaccine interventions (22, 35). Therefore, to assess whether vaccines would be able to afford protection if deletion mutant viruses arose, we performed HI assays using a panel of 6 separate chicken antisera raised against an antigenically distinct (34), older H9N2 isolate, A/chicken/Emirates/R66/2002 (here referred to as Em/R66). It was found again that all deletion mutants cross-reacted significantly less well than the wt UDL1/08 virus (P ≤ 0.0001) to the Em/R66 antisera (Fig. 1C and Table 1), with decreases of titers of between 1.4- and 5.4-fold. These results indicate that deletions within the 220 loop allow viruses to efficiently escape neutralizing antibodies such as those that may be generated by poultry vaccines.

Finally, we tested the antigenic cross-reactivity of the deletion mutant viruses with a single ferret antiserum raised against the H9N2 World Health Organization (WHO) candidate vaccine virus (CVV) seed strain most closely related to the wt UDL1/08 virus, A/Bangladesh/0994/2013 (BD/994) (36). We found that the L206F/Δ207–212 (a virus carrying the substitution L206F and a deletion of amino acids 207 to 212), Δ207–213, and Δ210–213 deletion mutants all had a 4-fold decrease in cross-reactivity compared to the wt UDL1/08 virus (Table 1). Surprisingly, the Δ208–212 and Δ211–215 deletion mutant viruses were inhibited 2-fold more efficiently by ferret BD/994 antisera than was the wt UDL1/08 virus.

Deletion mutants retain replicative fitness in chicken cells in vitro and ex vivo.

To assess whether the deletion mutant viruses were attenuated in vitro and ex vivo, we performed several low-multiplicity-of-infection (MOI) growth curves in Madin-Darby canine kidney (MDCK) cells, chicken kidney cells (CKCs), and chicken embryonic tracheal organ cultures (eTOCs). The deletion mutants generally replicated to titers comparable to that of the wt virus in all cells and tissues tested (Fig. 2A to C). Two mutants, Δ211–215 and Δ210–213, however, showed some replicative attenuation across several time points in eTOCs.

FIG 2.

FIG 2

Replication dynamics of 220 loop deletion viruses in vitro and ex vivo in mammalian and avian cells and tissues. (A) MDCK cells infected at an MOI of 0.001. (B) Primary chicken kidney cells infected at an MOI of 0.01. (C) eTOCs infected with 240 PFU/eTOC.

Some variation in plaque sizes in MDCK cells between the different viruses was observed: the wt, Δ208–212, and Δ208–213 viruses displayed similar, large-plaque phenotypes, while the L206F/Δ207–212 and Δ211–215 viruses displayed slightly smaller plaques, and the Δ210–213 virus displayed a small-plaque phenotype (data not shown). However, virus plaque size did not correlate with replication in MDCK cells.

Deletions in the 220 loop are stable after multiple egg passages and are viable in multiple H9N2 genetic backgrounds.

Previous studies investigating structural changes in HA, often after substitutions or deletions such as those described in this study, identified compensatory changes in either HA or neuraminidase (NA) that are selected in order to maintain viral fitness (37, 38). To investigate whether the deletion mutants would induce a similar pattern of HA or NA compensatory mutations, we performed 5 passages of our wt and deletion mutant viruses in embryonated chicken eggs. After passages 2 and 5, we sequenced the entire HA and NA coding regions and found that no further nonsynonymous substitutions occurred in either gene, with the sole exception of wt UDL1/08 virus HA1, which gained an N148K mutation, detectable by as early as passage 2. The role of this mutation has yet to be determined; however, we speculate that it may constitute egg adaptation.

Subsequently, we assessed whether the ability to tolerate deletions in the RBS was a universal or strain-specific trait of H9N2 viruses by evaluating the impact of loop deletions in both the BJ94 and American H9N2 lineages. Using reverse genetics, we generated a BJ94-lineage H9N2 virus, A/chicken/Wenzhou/606/2013, with both attempted deletions (Δ208–213 and Δ211–215) as well as an American-lineage H9N2 virus, A/turkey/Wisconsin/1/1966, with a Δ211–215 mutation. The successful rescue and replication of these additional mutants suggest that the ability to tolerate deletions in the RBS may indeed be a common trait of H9N2 HAs.

A deletion mutant retains infectivity, pathogenicity, and transmissibility in vivo in chickens.

Little to no change in the replication of the deletion mutant viruses was observed in vitro and ex vivo. Therefore, a single mutant (Δ208–213) was selected to determine comparative infectivity, transmissibility, and pathogenicity in chickens. The Δ208–213 mutant was chosen from among the deletion mutants because it appeared to have the highest level of replication in eTOCs. Two groups of seven naive, specific-pathogen-free (SPF) chickens were inoculated intranasally with 106 PFU of either the wt (UDL1/08) or the deletion mutant (Δ208–213) virus. At 24 h postinoculation, seven more naive birds were introduced (cohoused) with each group as contacts. Oropharyngeal and cloacal swabs were collected daily from each bird. Live-virus titration from oropharyngeal swabs indicated that both the wt and mutant viruses were comparatively infectious, since all birds exhibited robust shedding within 24 h postinoculation (Fig. 3A). In addition, all contact birds in both groups became infected at 1 day postcontact and shed infectious virus from the buccal cavity (Fig. 3B). Contact birds infected with the wt virus (UDL1/08) shed significantly larger amounts of virus from the buccal cavity on days 2 to 4, while the mutant virus (Δ208–213)-exposed contact birds shed significantly larger amounts of virus on day 5 postcontact. Directly inoculated birds in both groups, however, shed comparable levels of infectious virus from the buccal cavity throughout the experimental period (Fig. 3A). Although not statistically significant, 5/7 birds infected with the wt virus and 2/7 of their contacts shed infectious virus via the cloaca on one or more days, whereas both directly inoculated and contact birds infected with the Δ208–213 mutant shed no detectable infectious virus from the cloaca (Table 2).

FIG 3.

FIG 3

Comparative infectivity, shedding dynamics, transmission, tropism, and clinical presentation of the wt UDL1/08 and Δ208–213 viruses. (A) Mean oropharyngeal shedding of infectious virus by directly inoculated birds. For days 0 to 2, there were 7 birds per group; for day 3 onwards, there were 3 birds infected with the wt and 4 birds infected with deletion mutant due to culling and euthanization. Data show means ± standard errors. Student's t test was performed for comparisons between the viruses at each time point. *, 0.05 ≥ P > 0.01; **, 0.01 ≥ P > 0.001; ***, P ≥ 0.001. (B) Mean oropharyngeal shedding of infectious virus by contact birds (7 birds in each group throughout). (C) Presence of viral RNA in different tissues taken from directly infected birds at 2 days postinoculation. (D) Total clinical scores from individual birds recorded during the course of the experiment. † indicates culling of a bird for welfare reasons.

TABLE 2.

Cloacal shedding of wild-type and Δ208–213 viruses from chickens

Virus Contact or infected chicken % of birds with virus shedding (no. of birds shedding virus) Mean duration of shedding (days) Mean shedding titer (PFU/ml) (±SD)a
Wild type Infected 71.4 (5/7) 1.6 8.9 × 102 (±1.6 × 103)
Contact 28.6 (2/7) 1 5.9 × 103 (±8.0 × 103)
Δ208–213 Infected 0 (0/7) 0 ND
Contact 0 (0/7) 0 ND
a

ND indicates that no shedding was observed, and therefore, the mean titer could not be determined.

Birds were scored daily, in a blind manner, for clinical signs such as respiratory distress; red, crusty, and/or watery eyes; swollen heads; pale wattles; and reduced activity levels. Birds directly inoculated with the wt virus showed some mild clinical signs peaking at days 2 and 3 postinoculation, while birds directly inoculated with the deletion mutant (Δ208–213) virus showed no such signs (Fig. 3D). Contact birds infected with the wt virus exhibited mild to moderate clinical signs peaking at day 2 postexposure, resulting in one bird, which exhibited severe clinical signs, being euthanized for welfare reasons. In contrast, contact birds exposed to the mutant virus showed only mild clinical signs peaking on day 3 postexposure. The most common clinical signs observed in both groups were swollen heads, red eyes, and low activity levels.

Comparative intrahost tropism of the wt and the Δ208–213 deletion mutant virus was evaluated by quantifying the levels of viral M gene RNA in a number of different organs by quantitative reverse transcription-PCR (qRT-PCR); viral M gene RNA levels are a known correlate of infectious virus at early time points (9). On day 2 postinoculation, 3 birds from each group of directly inoculated birds were culled, and tissues were taken. Viral RNA was detected in the nasal tissue and liver in both groups; however, only the wt virus-infected birds had detectable viral RNA in the duodenum, trachea, lungs, and blood (Fig. 3C), and only birds infected with the mutant virus (Δ208–213) had viral RNA in the kidney and spleen. Neither virus was identified in the colon. wt virus RNA was found at higher concentrations in the trachea and lungs than was the Δ208–213 virus (with the mean M gene copy number ranging between 7.7 × 105 and 3.0 × 103 copies of the M gene/μg of total RNA for the wt in the trachea and lungs, compared to <1 × 102 M gene copies/μg of total RNA for the mutant in both organs). RNAs from both viruses were found at comparably high levels in the nasal tissue (3.2 × 105 to 1.9 × 105 copies of the M gene/μg of total RNA for the wt and mutant viruses, respectively).

Although no compensatory changes were seen after passage of the deletion mutants in embryonated eggs, in vivo transmission presents much more stringent selective pressure for less fit viruses (39, 40). Therefore, viruses present in buccal swabs from the contact birds of the mutant and wt UDL1/08 groups with the highest levels of shedding were used for sequencing, representing viruses that had undergone two passages in chickens. The HA and NA genes were sequenced to look for compensatory mutations; of the successful reactions (5 out of 7 in the mutant virus group and 7 out of 7 in the wt group), none of the HAs or NAs contained compensatory mutations.

Mutant viruses show increased avidity for a human-like α2,6-linked sialic acid analogue.

Due to the evidence that residues in the 220 loop can modulate H9 HA receptor binding (18, 29), receptor binding preferences of the wt and deletion mutant viruses were determined by using biolayer interferometry to quantify binding to different avian-like or human-like receptor analogues in a manner similar to that described previously (30).

H9N2 viruses of the G1 lineage, such as UDL1/08, were previously shown to have a strong receptor preference for the sulfated variant of the classical avian-like receptor analogue α-2,3-sialyllactosamine (3SLN), here referred to as 3SLN(6su) [Neu5Ac α-2,3 Gal β1,4(6-HSO3)GlcNAc]; weak binding to the human-like receptor α2,6-sialyllactosamine (6SLN); and no detectable binding to nonsulfated 3SLN (41). Compared to the wt UDL1/08 virus, all deletion mutants analyzed by using biolayer interferometry showed a substantial increase in binding to the human receptor analogue 6SLN (Fig. 4A to F). The Δ210–213 deletion mutant showed the largest increase in avidity for 6SLN (>75-fold-stronger relative binding), whereas the Δ208–213 mutant showed a modest increase (>7-fold increase) compared to the wt UDL1/08 virus. Additionally, all deletion mutants with the exception of the Δ210–213 mutant showed a significant (>2-fold) decrease in binding to the sulfated avian analogue 3SLN(6su) compared to the wt UDL1/08 virus (a 2.3-fold decrease for the Δ211–215 mutant and a 10-fold decrease for the Δ208–212 mutant). All deletion mutant viruses consistently exhibited some detectable binding to the nonsulfated avian receptor 3SLN, a property that the wt virus completely lacks, suggesting that the deletion mutant viruses generally exhibit less discrimination between different receptor analogues.

FIG 4.

FIG 4

Characterization of the receptor binding properties of 220 loop deletion viruses. Binding of purified virus to three different influenza virus receptor analogues was assayed by biolayer interferometry. All data are modeled with sigmoidal dose-response curves and the amalgamation of two repeats. Dotted curves show binding of the wt virus for direct comparison to the 220 loop deletion viruses. (A) wt UDL1/08 virus; (B) L206F/Δ207–212 mutant; (C) Δ208–212 mutant; (D) Δ208–213 mutant; (E) Δ210–213 mutant; (F) Δ211–215 mutant.

Mutant viruses replicate to higher titers in primary human airway cells.

Due to the observed increased binding of the deletion mutant viruses to 6SLN, we were interested to compare the replication kinetics of the wt UDL1/08 virus and the mutant viruses in primary human airway epithelial (HAE) cultures (Fig. 5). We compared the Δ208–213 and Δ210–213 mutant viruses (chosen due to having the most modest and largest increases in 6SLN binding, respectively) to a pandemic H1N1 virus, A/England/195/2009 (here referred to as H1N1pdm09). As expected, H1N1pdm09 replicated to significantly higher titers in human cells than did the avian-origin wt UDL1/08 virus at all time points until 48 h postinfection, with consistent >100-fold-higher titers. At early time points (<36 h postinfection), both mutant viruses grew to titers higher than that of the wt UDL1/08 virus, with titers being between 1.5- and 67-fold higher for the Δ208–213 virus and between 20- and 120-fold higher for the Δ210–213 virus. However, only the Δ210–213 mutant reached a significantly higher titer at any time point (at 8 h postinfection, as determined by one-way ANOVA with multiple comparisons). Overall, these results demonstrated that the deletion mutants had a replicative advantage over the wt UDL1/08 virus in this mammalian ex vivo culture system.

FIG 5.

FIG 5

Infection of human primary airway cells with deletion mutant viruses. HAE cultures were infected with 1,000 PFU/transwell. The infectious virus titer was determined by a plaque assay on MDCK cells. Data show means ± standard errors. Significance (* indicates a P value of >0.05) was determined by one-way ANOVA with multiple comparisons.

Deletion mutant viruses have lower HA stability than the wild-type virus.

In addition to receptor binding preference, HA pH stability has been repeatedly shown to be an important factor in the adaption of AIVs to efficient airborne transmission in humans or ferrets. AIVs generally have a less stable HA and therefore fuse at a higher pH than human influenza viruses (41, 42). Efficient airborne transmission of AIVs in mammalian model systems (i.e., the ferret) is thought to require mutations in HA that stabilize the molecule to a lower pH of fusion (32, 43). These properties may enable better survival of virions in the harsh microenvironment of respiratory droplets and the acidic mammalian nasal passage.

Previous studies have shown that changes at the HA trimer interface, or in the RBS, can modulate pH stability in H5N1 and H7N9 viruses (32, 44, 45). As well as directly measuring pH stability, we also tested the comparative thermal stability, a well-known correlate of pH stability (45, 46), of the mutant viruses. Vero cells were infected with the respective viruses, allowing cell surface expression of HA and NA, followed by treatment with trypsin and then buffers across a pH range to allow syncytium formation. Syncytium formation was quantified as previously described (41). All deletion mutant viruses demonstrated increases in fusion pH (between +0.14 to 0.36 pH units) compared to the wt virus (Fig. 6A and B). Interestingly, there was a good correlation between the size of the deletion and the change in pH stability, with the pairs of viruses bearing deletions of either 5 or 6 amino acids having very similar changes (P = 0.0023 by a Student t test comparing the effects of the of 5- and 6-amino-acid deletions). Viruses with 6 amino acids deleted had the smallest change in pH stability, while those with 5 amino acids deleted had the largest, and the single 4-amino-acid deletion had intermediate stability. These results indicate that the deletion size, rather than the precise amino acid position, may be the defining factor for the pH stability of these viruses.

FIG 6.

FIG 6

pH stability of 220 loop deletion mutants. (A) Syncytium formation of deletion mutants under different pH conditions (pHs are shown above each image). Shown are data for representative pH conditions where viruses form maximal or minimal syncytia. (B) Summary of predicted pHs of fusion of deletion mutants and the wt virus as determined by 50% syncytium formation in Vero cells. Numbers above the bars show increases in the pH of fusion of mutant viruses compared with the wt virus.

To test the thermal stability of the deletion mutants, 128 hemagglutination units (HAU) of the wt or deletion mutant viruses were heated at either 50°C or 56°C over a 4-h time course. Samples were taken at regular time points, and a hemagglutination assay was performed to determine changes in virus hemagglutination titers. At 50°C, the Δ211–215, Δ208–212, and Δ210–213 mutants were the least stable viruses, with decreases in hemagglutination titers of between 4- and 64-fold compared to the wt UDL1/08 virus (Fig. 7A). At 56°C, the L206F/Δ207–212 deletion mutant virus also displayed lower stability than the wt virus (Fig. 7B). The Δ208–213 deletion mutant virus, although also less stable than the wt, retained stability comparable to that of Em/R66. As previously reported for multiple influenza virus subtypes (45, 47), we found that thermal stability showed a strong correlation with pH stability (Spearman's rho = 0.92). Overall, these results further demonstrate the destabilizing effect of 220 loop deletions.

FIG 7.

FIG 7

Thermal stability of 220 loop deletion mutants. The thermal stability of hemagglutinin was assayed based on the ability to hemagglutinate chicken red blood cells after incubation at either 50°C (A) or 56°C (B) for a time course.

DISCUSSION

Influenza viruses evolve rapidly due to high mutation rates, mutational robustness and plasticity, and the ability to readily reassort (48, 49). Mutations in the HA glycoprotein are known to be particularly influential on modulating the overlapping and interrelated properties of receptor specificity, host and tissue tropism, pathogenicity, and antigenicity (32, 43, 50). Conventional avian influenza vaccines typically lose efficacy as HAs undergo antigenic drift, and several research groups have suggested that the widespread use of poultry vaccines may even contribute to driving antigenic drift (21, 22, 24, 51, 52). Recently, we generated a panel of “antigenic drift-like” escape mutants (through in vitro selection with MAbs), some of which contained deletions within the 220 loop region of the HA RBS (34). In this study, we have shown that these loop deletion mutants are still able to replicate to titers comparable to those of wt viruses in chicken cells in vitro and ex vivo. In an in vivo model system, selected deletion mutants were able to replicate and be transmitted between chickens; however, these mutants were slightly attenuated compared to the wt virus. The deletion mutant viruses were able to escape neutralization not only from their cognate selecting MAbs but also from both homologous and heterologous chicken and ferret antisera. In addition, these viruses exhibited various degrees of increased binding to the human-like α2,6 receptor analogue and greater replicative ability in primary human airway cells than the wt virus, indicating possibly increased zoonotic potential. However, the deletion mutants generally had lower pH and thermal stability than the wt virus, a property that may increase their pathogenicity in poultry (53, 54) but would likely limit their pandemic potential without compensatory stabilizing mutations (32, 55).

Our results suggest that HA deletion mutant viruses such as these may be slightly attenuated; they could potentially outcompete wild-type viruses in vaccinated poultry while incidentally modulating other viral phenotypes such as receptor binding and pH stability. The possibility that vaccine-induced immunity may influence antigenic drift was previously explored through studies with comparative molecular epidemiology; however, the underlying process remains poorly understood and merits further investigation (22, 51, 56). Both deletion mutant viruses tested here for their growth in primary human airway cells, Δ208–213 and Δ210–213, exhibited increased replication compared to the wt UDL1/08 virus. The Δ208–213 mutant showed only a mild increase in replication compared to the wt UDL1/08 virus and only a moderate increase (>7-fold) in 6SLN binding. The Δ210–213 mutant showed a larger increase in replication and as well as a larger increase in 6SLN binding (>75-fold). As expected, this demonstrates that 6SLN binding correlates well with replication in primary human cells. Neither deletion mutant, however, grew to levels comparable to those of human H1N1pdm09. There could be multiple reasons for this; for example, although both deletion mutants displayed some avidity toward 6SLN, this level of binding was still relatively low compared to that of human H1N1pdm09 viruses (41). Additionally, UDL1/08, being an avian-adapted virus, does not naturally possess many of the molecular markers associated with mammalian adaption in H1N1pdm09 and other human influenza viruses, for example, PB2-Q591K, PB2-E627K, or PB2-D701N (57, 58).

To explain how changes in the phenotypes of deletion mutants may be linked to changes in structure, we utilized homology modeling conducted with the Phyre2 protein fold recognition server. Initially, we threaded the sequence of UDL1/08 HA (minus the transmembrane domain and cytoplasmic tail) to the only currently solved H9 HA structure (a BJ94-lineage virus, A/Swine/Hong Kong/9/98) (PDB accession number 1JSD). We then aligned the predicted structures of the deletion mutants and compared the projected conformations of the 220 loop regions. Notably, the 220 loop region, which forms a key region of the antigenic site H9-A (34), is anticipated to be in a different conformation in all deletion mutant structures compared to the wt UDL1/08 virus. This property may explain the observed changes in the antigenicity of the deletion mutant viruses (Fig. 8). Additionally, several viruses were predicted to have structural variations at the trimer interface that may modulate pH stability (59, 60). All predicted structures showed a different conformation of residues 216 and 217 (residues 226 and 227 according to H3 numbering), both of which are known to modulate H9 HA receptor binding specificity (18, 29).

FIG 8.

FIG 8

Modeling of 220 loop deletion mutants. Shown are aligned predicted structures of HA receptor binding sites in wt UDL1/08 and 220 loop deletion mutants. Structural predictions were made by using Phyre2 (73) (Imperial College London and BBSRC). Structural alignments were made by using PyMOL (Schrödinger LLC) (74).

One interesting feature of the Δ208–213 deletion mutant virus, when tested in vivo, was its complete lack of cloacal shedding and intestinal tropism. We speculate that the deletion mutant failed to disseminate into the gastrointestinal tract due to insufficient replicative fitness, as evidenced by the low virus titers observed at early time points from buccal swabs. Another possibility is that the deletion mutant's lower pH stability, shifted receptor binding profile (away from sulfated 3SLN and toward 6SLN), or a combination of these factors did not favor transport through the highly acidic gizzard and subsequent attachment to and replication in the gut epithelium (known to contain high α2,3- and low α2,6-SA levels) (61, 62). The apparent lack of intestinal tropism found in the mutant virus, combined with the 100% transmission rate, again shows the apparent dispensability of transmission through the oral-fecal route in our model system (9).

Naturally occurring H9N2 virus isolates containing 220 loop deletions have been reported from China (6) and, very recently, from Pakistan (63). The report from China described a BJ94-lineage virus, A/chicken/Shandong/818/2012 (SD/818), with a single amino acid deletion at position 217 (H9 mature numbering; position 227 according to H3 numbering), that was isolated from commercial chicken flocks showing high morbidity and mortality rates. The SD/818 virus was subsequently evaluated to be moderately pathogenic under laboratory conditions in SPF birds with an intravenous pathogenicity index (IVPI) score of 1.0 (high pathogenicity is defined as an IVPI score of >1.2). In comparison, a genetically closely related H9N2 virus with a full-length HA not harboring the 220 loop deletion had an IVPI score of 0 (7, 58). We speculate that the increased pathogenicity of SD/818 may be due to a higher pH of fusion of its HA molecule, since previous studies have shown that an unstable HA molecule with a high pH of fusion correlates well with virus pathogenicity in avian hosts (53, 54). Our present study suggests that deletions in the 220 loop may incur a stability cost; however, data on the HA stability phenotype of SD/818 are lacking, nor is there information regarding the vaccination status of the birds from which this virus was isolated. Furthermore, there has been a preliminary report of a mutant H9N2 virus, from Pakistan, that has 6 amino acids deleted in the 220 loop region (63), further supporting the hypothesis that these viruses may arise spontaneously in poultry.

Other virus subtypes with 220 loop deletions (notably H3 and H7) have been generated in vitro as well as being found in the field. During an escape mutant analysis similar to our original study (34), Daniels et al. generated a mutant of H3N2 laboratory strain X-31 with a 7-amino-acid deletion from positions 214 to 220 (equivalent H9 mature numbering; positions 224 in 230 according to H3 numbering) (64). This H3 deletion mutant exhibited altered receptor binding compared to wild-type strain X-31, such that instead of a typical α2,6 binding preference, the mutant bound both α2,6- and α2,3-linked SA, thereby losing its preference toward one sugar or the other, in a manner similar to that of our H9N2 deletion mutants. Additionally, the X-31 deletion mutant showed an increase in the pH of fusion of 0.2 pH units, indicating reduced HA stability, again similar to our H9 220 loop deletion mutants.

Between 1994 and 2006, a sublineage of low-pathogenicity H7N2 viruses that harbored an 8-amino-acid deletion in the 220 loop (positions 211 to 218, equivalent to H9 mature numbering; positions 221 to 228 according to H3 numbering) circulated in chickens on the East Coast of the United States. These H7 viruses were shown to have a higher propensity for binding human-like receptors by glycan microarray analysis than other contemporary avian H7 viruses and were able to efficiently replicate in ferrets (37, 65, 66). A single human case of infection by this H7 virus was reported previously (67). A structural study by Yang et al. suggests that HA was able to functionally compensate for the loss of a 220 loop through substitutions in peripheral residues around the RBS (37), a feature that we did not observe for our mutants after either in ovo or in vivo passage.

To conclude, our findings highlight the importance of continued vigilant surveillance of avian populations for the emergence of novel influenza virus variants, particularly in vaccinated populations. If viruses are identified with deletions in the 220 loop region (particularly in H5, H7, or H9 viruses), these isolates should be further evaluated for their zoonotic risk potential through assessments of receptor binding preference and increased replication in mammalian models. The emergence of viruses with 220 loop deletions in poultry should also trigger a reassessment of vaccine efficacy, as our data suggest that loop deletion viruses are likely to exhibit markedly different antigenicities compared to those of closely related progenitor viruses. Without further stabilizing mutations in HA, we suggest that 220 loop deletion viruses, although they may pose an increased zoonotic risk compared to other field strains, are unlikely to be able to be transmitted from human to human by the airborne route and therefore are unlikely to pose a particularly elevated pandemic threat. Overall, this study contributes to the body of literature on AIV molecular determinants associated with zoonotic risk and emergence and underscores the complexity of predicting which field strains are most likely to predominate or may develop the capacity for human-to-human transmission.

MATERIALS AND METHODS

Ethics statement.

All animal studies and procedures were carried out in strict accordance with European and United Kingdom Home Office regulations and the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012. This work was carried out under UK Home Office-approved project license numbers 30/2683 and 30/2952. As part of this process, the work was subjected to scrutiny and approval by the Ethics Committee at The Pirbright Institute.

Cells, eggs, and tissues.

MDCK cells, HEK 293T cells, and Vero cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C in 5% CO2. Virus was grown in 10-day-old SPF embryonated eggs and harvested at 48 h postinoculation. CKCs and eTOCs were prepared as previously described (68, 69). Primary human airway epithelial cultures, MucilAir, were purchased from Epithelix SAS (France). Cells were obtained from donor pools of nasal tissue and were maintained in MucilAir culture medium at 37°C in 5% CO2.

Recombinant viruses and virus rescue.

H9N2 avian influenza virus UDL1/08 was used throughout this study unless otherwise stated. UDL1/08 was rescued by using a standard influenza virus 8-plasmid bidirectional reverse-genetics system as previously described (70). Loop deletion HA plasmids of UDL1/08 and the other H9N2 viruses of BJ94 (A/chicken/Wenzhou/606/2013) and American (A/turkey/Wisconsin/1/1966) lineages were generated by site-directed mutagenesis as described previously (34). High-egg-growth reassortant viruses were generated by rescuing HA and NA of H9N2 viruses with the remaining 6 genes of the high-egg-growth strain A/Puerto Rico/8/1934 H1N1 (PR8), here referred to as 2:6 reassortants. Non-UDL1/08 H9N2 viruses were rescued from their HA rescue plasmid with the NA plasmid from UDL1/08 and the remaining genes from PR8. Viruses were titrated by a virus plaque assay or a 50% tissue culture infective dose (TCID50) assay (in the case of microneutralization assays) as previously described (71). Deletion mutant PFU and TCID50 values were relative for all viruses tested.

Hemagglutination inhibition and microneutralization assays.

Hemagglutination inhibition assays and microneutralization assays were carried out by using 2:6 reassortants and whole UDL1/08 virus, respectively. Both assays were performed as previously described (71). The HI assay utilized 1% chicken red blood cells.

Virus growth curves.

MDCK cells and primary chicken kidney cells were infected with recombinant whole UDL1/08 wt and mutant viruses at MOIs of 0.001 and 0.01, respectively (240 or 2,400 PFU/6-well plate well) for 1 h at 37°C. Cells were then washed twice with phosphate-buffered saline (PBS) to remove unbound virus, and 2 ml of virus growth medium (DMEM plus 2 μg/ml tosyl phenylalanyl chloromethyl ketone [TPCK]-treated trypsin for MDCK cells and Eagle's minimum essential medium [EMEM], 7% bovine serum albumin [BSA], and 10% tryptose phosphate broth [TPB] for CKCs) was added. Infected culture medium was harvested at 12, 24, 48, and 72 h postinfection, and virus titers were estimated in triplicate by using MDCK cell-based plaque assays. eTOCs were infected in sextuplicate with 240 PFU of virus/eTOC and sampled at 12, 18, 24, and 36 h postinfection. For growth curves in human airway epithelial (HAE) cultures, cells were first washed with serum-free medium to remove excess mucus and then infected with 1,000 PFU/transwell at the apical surface. Virus was collected by washing the cells at the apical surface with 200 μl of serum-free medium at 8, 12, 24, 36, and 48 h postinfection.

Passage of virus in eggs.

Whole virus was diluted in a 10-fold serial dilution in PBS; each dilution was added to a single egg. Eggs were harvested at 2 days postinoculation and tested for the presence of virus by hemagglutination. For each virus, the highest dilution with a positive HA titer was then used for further passage and/or sequencing.

Sequencing of virus.

Sequencing of virus HA and NA genes was performed as described previously (34). Briefly, RNA from viruses was extracted from swab-soaked viral transport medium, egg allantoic fluid, or cell culture medium by using the QIAamp viral RNA minikit (Qiagen). A Verso cDNA synthesis kit (Thermo Scientific) was used to perform reverse transcription with the universal FluA primer. PCR was undertaken by using primers specific for HA1, HA2, and NA adjuncted with 3′ M13F and M13R sequencing motifs (sequences of primers are available upon request). The QIAquick PCR purification kit (Qiagen) was used to purify the resulting products, which were then sequenced by using the M13F and M13R primers.

Animal studies.

For in vivo studies on the comparative properties of the Δ208–213 loop deletion virus and the wt UDL1/08 virus, 3-week-old specific-pathogen-free Rhode Island Red birds were housed in isolators, with 7 birds per isolator, 1 day prior to infection. At day 0, birds were infected intranasally with 106 PFU of virus per bird. On day 1 postinfection, seven contact birds were added to each isolator. Cloacal and oropharyngeal swabs were obtained from all birds on days 0 to 6, 8, and 10, and swabs were soaked and vortexed in virus transport medium (medium 199, 0.5% BSA, 2 × 106 U penicillin G [Sigma], 200 mg/liter streptomycin [Sigma], 2 × 106 U/liter polymyxin B [Sigma], 250 mg/liter gentamicin [Sigma], 5 × 105 U/liter nystatin [Sigma], 60 mg/liter ofloxacin HCl [Sigma], and 200 mg/liter sulfamethoxazole [Sigma]). The viral titer of the inoculum in PFU was then determined on MDCK cells. On day 2, three directly infected birds from each group were culled by pentobarbital overdose, and tissues were removed and frozen in RNAlater (Life Technologies). At 14 days postinfection, all birds were euthanized by pentobarbital overdose and were bled for serum preparation.

Detection of virus in animal tissues.

Tissues from infected and control birds were homogenized in TRIzol (Life Technologies). The aqueous fraction was then extracted after mixing with chloroform and centrifugation. An RNeasy minikit (Qiagen) was then used for subsequent steps of RNA extraction. qRT-PCR was performed by using a Superscript III Platinum One-Step qRT-PCR kit (Life Technologies). Primer and probe sets against the M gene were used as previously described (9, 72). Reaction conditions used were 50°C for 5 min and 95°C for 2 min followed by 40 cycles of 95°C for 3 s and then 60°C for 30 s. T7-transcribed RNA standards of the M gene were used to generate a standard curve to quantify observed M gene copy numbers.

Homology modeling of hemagglutinin structures.

Structural prediction of H9 HA and derivative loop deletion mutants of UDL1/08 was performed by using Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2) (73). Images were generated and rendered in PyMOL (https://www.pymol.org/) (74).

Thermal stability assay.

2:6 recombinant H9N2 viruses were diluted to a stock of 128 HAU/50 μl. Virus was then heat treated on a heat block at either 50°C or 56°C for various times (0, 15, 30, 60, 120, 180, and 240 min). Heat-treated viruses were then assayed for HA titers in quadruplicate.

Syncytium formation assays.

Syncytium formation assays were performed as previously described (41). Vero cells were virally infected with a high MOI of >3. At 16 h postinfection, cells were treated with trypsin for 15 min and then exposed to morpholineethanesulfonic acid (MES) buffers adjusted across a pH range. At 3 h posttreatment, cells were fixed and stained with Giemsa stain (Sigma-Aldrich). Images were taken on the Evos XL cell imaging system (Life Technologies). Percent syncytium formation was calculated from 5 random fields per virus per well. The predicted pH of fusion was calculated from fitting sigmoidal dose-response curves to the data by using GraphPad Prism version 6 (GraphPad Software).

Virus purification.

Virus from clarified egg allantoic fluid was initially pelleted by ultracentrifugation at 27,000 rpm for 2 h. Pellets were resuspended in PBS and homogenized by using a glass homogenizer. The virus suspension was then centrifuged on a continuous 30 to 60% sucrose gradient at 27,000 rpm for 2 h. The virus-containing band was then diluted in PBS, and virus was pelleted once again at 27,000 rpm for 2 h. Finally, virus was resuspended in PBS–0.01% azide. The virus concentration was determined by using an enzyme-linked immunosorbent assay (ELISA) against the virus nucleoprotein (NP) as described previously (30).

Biolayer interferometry.

Binding of virus to sialic acid receptor analogues was measured by using an Octet Red biolayer interferometer (Pall FortéBio) as previously described (41). Briefly, receptor analogues of sialoglycopolymers consisting of a 30-kDa polyacrylamide backbone conjugated to 20 mol% trisaccharide 6SLN, 3SLN, or 3SLN(6su) and 5 mol% biotin (Lectinity Holdings). Sialylglycopolymers were immobilized on streptavidin-coated biosensors (Pall FortéBio) at concentrations ranging from 0.01 to 0.5 μg/ml in a solution containing 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, and 0.005% Tween 20 (HBS-EP). Virus was diluted in HBS-EP containing 10 μM oseltamivir carboxylate (Roche) and 10 μM zanamivir (GSK) to a concentration of 100 pM. The association of virus with the immobilized receptors was measured at 20°C for 30 min. Virus binding amplitudes were normalized to fractional saturation and plotted as a function of sugar loading. Virus relative estimated dissociation constants (KDs) were calculated as described in our previous study (41).

ACKNOWLEDGMENTS

We thank Jürgen Stech of the Friedrich Loeffler Institute for the reverse-genetics system of A/chicken/Emirates/R66/2002 (H9N2).

The work described here was funded by The Pirbright Institute studentship grant BBS/E/00001759; BBSRC Avian Disease Programme grant BBS/E/I/00001708; BBSRC ZELS grant BB/L018853/1; and Medical Research Council programs U117585868, U117512723, and U117570592. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

We state that we have no conflicts of interest.

T.P.P., M.I., W.S.B., H.S., J.E.B., and S.R.M. conceived of and planned experiments. T.P.P., D.J.B., J.J., J.-R.S., P.C., J.E.S., H.S., and M.I. performed the experiments. T.P.P., D.J.B., J.E.B., S.R.M., and M.I. analyzed data. D.J.B., J.J., S.R.M., J.E.B., and W.S.B. contributed reagents. T.P.P. and M.I. drafted the manuscript. T.P.P., D.J.B., J.J., J.E.S., J.E.B., S.R.M., H.S., W.S.B., and M.I. proofread, edited, and revised the manuscript.

REFERENCES

  • 1.Qi X, Jiang D, Wang H, Zhuang D, Ma J, Fu J, Qu J, Sun Y, Yu S, Meng Y, Huang Y, Xia L, Li Y, Wang Y, Wang G, Xu K, Zhang Q, Wan M, Su X, Fu G, Gao GF. 2014. Calculating the burden of disease of avian-origin H7N9 infections in China. BMJ Open 4:e004189. doi: 10.1136/bmjopen-2013-004189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dalby AR, Iqbal M. 2014. A global phylogenetic analysis in order to determine the host species and geography dependent features present in the evolution of avian H9N2 influenza hemagglutinin. PeerJ 2:e655. doi: 10.7717/peerj.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fusaro A, Monne I, Salviato A, Valastro V, Schivo A, Amarin NM, Gonzalez C, Ismail MM, Al-Ankari A-R, Al-Blowi MH, Khan OA, Maken Ali AS, Hedayati A, Garcia Garcia J, Ziay GM, Shoushtari A, Al Qahtani KN, Capua I, Holmes EC, Cattoli G. 2011. Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J Virol 85:8413–8421. doi: 10.1128/JVI.00219-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Guo YJ, Krauss S, Senne DA, Mo IP, Lo KS, Xiong XP, Norwood M, Shortridge KF, Webster RG, Guan Y. 2000. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267:279–288. doi: 10.1006/viro.1999.0115. [DOI] [PubMed] [Google Scholar]
  • 5.Nili H, Asasi K. 2003. Avian influenza (H9N2) outbreak in Iran. Avian Dis 47:828–831. doi: 10.1637/0005-2086-47.s3.828. [DOI] [PubMed] [Google Scholar]
  • 6.Zhang Y, Guo X, Qi J, Liu L, Wang J, Xu S, Wang J, Yin Y. 2014. Complete genome sequence of an H9N2 influenza virus lethal to chickens. Genome Announc 2:e00929-14. doi: 10.1128/genomeA.00929-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang J, Cao Z, Guo X, Zhang Y, Wang D, Xu S, Yin Y. 2016. Cytokine expression in three chicken host systems infected with H9N2 influenza viruses with different pathogenicities. Avian Pathol 45:630–639. doi: 10.1080/03079457.2016.1193665. [DOI] [PubMed] [Google Scholar]
  • 8.El Houadfi M, Fellahi S, Nassik S, Guerin JL, Ducatez MF. 2016. First outbreaks and phylogenetic analyses of avian influenza H9N2 viruses isolated from poultry flocks in Morocco. Virol J 13:140. doi: 10.1186/s12985-016-0596-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.James J, Howard W, Iqbal M, Nair V, Barclay WS, Shelton H. 2016. Influenza A virus PB1-F2 protein prolongs viral shedding in chickens lengthening the transmission window. J Gen Virol 97:2516–2527. doi: 10.1099/jgv.0.000584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS, Guan Y. 2005. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol 43:5760–5767. doi: 10.1128/JCM.43.11.5760-5767.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.International Centre for Diarrhoeal Disease Research. 2011. Outbreak of mild respiratory disease caused by H5N1 and H9N2 infections among young children in Dhaka, Bangladesh, 2011. Health Sci Bull 9:5–12. [Google Scholar]
  • 12.Huang Y, Li X, Zhang H, Chen B, Jiang Y, Yang L, Zhu W, Hu S, Zhou S, Tang Y, Xiang X, Li F, Li W, Gao L. 2015. Human infection with an avian influenza A (H9N2) virus in the middle region of China. J Med Virol 87:1641–1648. doi: 10.1002/jmv.24231. [DOI] [PubMed] [Google Scholar]
  • 13.World Health Organization. 2015. Influenza at the human-animal interface, summary and assessment as of 3 March 2015. World Health Organization, Geneva, Switzerland: http://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_3_March_2015.pdf?ua=1 Accessed 30 March 2017. [Google Scholar]
  • 14.Khan SU, Anderson BD, Heil GL, Liang S, Gray GC. 2015. A systematic review and meta-analysis of the seroprevalence of influenza A(H9N2) infection among humans. J Infect Dis 212:562–569. doi: 10.1093/infdis/jiv109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kimble JB, Angel M, Wan H, Sutton TC, Finch C, Perez DR. 2014. Alternative reassortment events leading to transmissible H9N1 influenza viruses in the ferret model. J Virol 88:66–71. doi: 10.1128/JVI.02677-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kimble JB, Sorrell E, Shao H, Martin PL, Perez DR. 2011. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc Natl Acad Sci U S A 108:12084–12088. doi: 10.1073/pnas.1108058108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sorrell EM, Wan H, Araya Y, Song H, Perez DR. 2009. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A 106:7565–7570. doi: 10.1073/pnas.0900877106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sang X, Wang A, Ding J, Kong H, Gao X, Li L, Chai T, Li Y, Zhang K, Wang C, Wan Z, Huang G, Wang T, Feng N, Zheng X, Wang H, Zhao Y, Yang S, Qian J, Hu G, Gao Y, Xia X. 2015. Adaptation of H9N2 AIV in guinea pigs enables efficient transmission by direct contact and inefficient transmission by respiratory droplets. Sci Rep 5:15928. doi: 10.1038/srep15928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Li X, Shi J, Guo J, Deng G, Zhang Q, Wang J, He X, Wang K, Chen J, Li Y, Fan J, Kong H, Gu C, Guan Y, Suzuki Y, Kawaoka Y, Liu L, Jiang Y, Tian G, Li Y, Bu Z, Chen H. 2014. Genetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 avian influenza viruses. PLoS Pathog 10:e1004508. doi: 10.1371/journal.ppat.1004508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Shanmuganatham KK, Jones JC, Marathe BM, Feeroz MM, Jones-Engel L, Walker D, Turner J, Rabiul Alam SM, Kamrul Hasan M, Akhtar S, Seiler P, McKenzie P, Krauss S, Webby RJ, Webster RG. 2016. The replication of Bangladeshi H9N2 avian influenza viruses carrying genes from H7N3 in mammals. Emerg Microbes Infect 5:e35. doi: 10.1038/emi.2016.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhang P, Tang Y, Liu X, Peng D, Liu W, Liu H, Lu S, Liu X. 2008. Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5 year period (1998-2002). J Gen Virol 89:3102–3112. doi: 10.1099/vir.0.2008/005652-0. [DOI] [PubMed] [Google Scholar]
  • 22.Park KJ, Kwon HI, Song MS, Pascua PN, Baek YH, Lee JH, Jang HL, Lim JY, Mo IP, Moon HJ, Kim CJ, Choi YK. 2011. Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J Gen Virol 92:36–50. doi: 10.1099/vir.0.024992-0. [DOI] [PubMed] [Google Scholar]
  • 23.Banet-Noach C, Perk S, Simanov L, Grebenyuk N, Rozenblut E, Pokamunski S, Pirak M, Tendler Y, Panshin A. 2007. H9N2 influenza viruses from Israeli poultry: a five-year outbreak. Avian Dis 51:290–296. doi: 10.1637/7590-040206R1.1. [DOI] [PubMed] [Google Scholar]
  • 24.Bahari P, Pourbakhsh SA, Shoushtari H, Bahmaninejad MA. 2015. Molecular characterization of H9N2 avian influenza viruses isolated from vaccinated broiler chickens in northeast Iran. Trop Anim Health Prod 47:1195–1201. doi: 10.1007/s11250-015-0848-x. [DOI] [PubMed] [Google Scholar]
  • 25.Chambers TM, Kawaoka Y, Webster RG. 1988. Protection of chickens from lethal influenza infection by vaccinia-expressed hemagglutinin. Virology 167:414–421. doi: 10.1016/S0042-6822(88)90103-1. [DOI] [PubMed] [Google Scholar]
  • 26.McDonald NJ, Smith CB, Cox NJ. 2007. Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J Gen Virol 88:3209–3213. doi: 10.1099/vir.0.83184-0. [DOI] [PubMed] [Google Scholar]
  • 27.Harvey WT, Benton DJ, Gregory V, Hall JP, Daniels RS, Bedford T, Haydon DT, Hay AJ, McCauley JW, Reeve R. 2016. Identification of low- and high-impact hemagglutinin amino acid substitutions that drive antigenic drift of influenza A(H1N1) viruses. PLoS Pathog 12:e1005526. doi: 10.1371/journal.ppat.1005526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC. 1983. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304:76–78. doi: 10.1038/304076a0. [DOI] [PubMed] [Google Scholar]
  • 29.Wan H, Perez DR. 2007. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol 81:5181–5191. doi: 10.1128/JVI.02827-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ, Vachieri SG, Christodoulou E, Walker PA, Liu J, Skehel JJ, Gamblin SJ, Hay AJ, Daniels RS, McCauley JW. 2012. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A 109:21474–21479. doi: 10.1073/pnas.1218841110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74:8502–8512. doi: 10.1128/JVI.74.18.8502-8512.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420–428. doi: 10.1038/nature10831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534–1541. doi: 10.1126/science.1213362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Peacock T, Reddy K, James J, Adamiak B, Barclay W, Shelton H, Iqbal M. 2016. Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape. Sci Rep 6:18745. doi: 10.1038/srep18745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, Xu G, Sun H, Wang M, Wen C, Wei Y, Wang D, Zhu B, Lemmon G, Jiao Y, Duan S, Wang Q, Du Q, Sun M, Bao J, Sun Y, Zhao J, Zhang H, Wu G, Liu J, Webster RG. 2015. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc Natl Acad Sci U S A 112:548–553. doi: 10.1073/pnas.1422456112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.World Health Organization. 2016. Summary of status of development and availability of A(H9N2) candidate vaccine viruses 29 February 2016. World Health Organization, Geneva, Switzerland. [Google Scholar]
  • 37.Yang H, Chen LM, Carney PJ, Donis RO, Stevens J. 2010. Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog 6:e1001081. doi: 10.1371/journal.ppat.1001081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Diederich S, Berhane Y, Embury-Hyatt C, Hisanaga T, Handel K, Cottam-Birt C, Ranadheera C, Kobasa D, Pasick J. 2015. Hemagglutinin-neuraminidase balance influences the virulence phenotype of a recombinant H5N3 influenza A virus possessing a polybasic HA0 cleavage site. J Virol 89:10724–10734. doi: 10.1128/JVI.01238-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lakdawala SS, Jayaraman A, Halpin RA, Lamirande EW, Shih AR, Stockwell TB, Lin X, Simenauer A, Hanson CT, Vogel L, Paskel M, Minai M, Moore I, Orandle M, Das SR, Wentworth DE, Sasisekharan R, Subbarao K. 2015. The soft palate is an important site of adaptation for transmissible influenza viruses. Nature 526:122–125. doi: 10.1038/nature15379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Russier M, Yang G, Rehg JE, Wong SS, Mostafa HH, Fabrizio TP, Barman S, Krauss S, Webster RG, Webby RJ, Russell CJ. 2016. Molecular requirements for a pandemic influenza virus: an acid-stable hemagglutinin protein. Proc Natl Acad Sci U S A 113:1636–1641. doi: 10.1073/pnas.1524384113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Peacock TP, Benton DJ, Sadeyen JR, Chang P, Sealy JE, Bryant JE, Martin SR, Shelton H, McCauley JW, Barclay WS, Iqbal M. 2017. Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusion. Emerg Microbes Infect 6:e11. doi: 10.1038/emi.2016.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Galloway SE, Reed ML, Russell CJ, Steinhauer DA. 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151. doi: 10.1371/journal.ppat.1003151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Linster M, van Boheemen S, de Graaf M, Schrauwen EJ, Lexmond P, Manz B, Bestebroer TM, Baumann J, van Riel D, Rimmelzwaan GF, Osterhaus AD, Matrosovich M, Fouchier RA, Herfst S. 2014. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell 157:329–339. doi: 10.1016/j.cell.2014.02.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schrauwen EJ, Richard M, Burke DF, Rimmelzwaan GF, Herfst S, Fouchier RA. 2016. Amino acid substitutions that affect receptor binding and stability of the hemagglutinin of influenza A/H7N9 virus. J Virol 90:3794–3799. doi: 10.1128/JVI.03052-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Watanabe Y, Arai Y, Daidoji T, Kawashita N, Ibrahim MS, El-Gendy Eel D, Hiramatsu H, Kubota-Koketsu R, Takagi T, Murata T, Takahashi K, Okuno Y, Nakaya T, Suzuki Y, Ikuta K. 2015. Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients. mBio 6:e00081-15. doi: 10.1128/mBio.00081-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J. 2011. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One 6:e18577. doi: 10.1371/journal.pone.0018577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wharton SA, Skehel JJ, Wiley DC. 1986. Studies of influenza haemagglutinin-mediated membrane fusion. Virology 149:27–35. doi: 10.1016/0042-6822(86)90083-8. [DOI] [PubMed] [Google Scholar]
  • 48.Heaton NS, Sachs D, Chen CJ, Hai R, Palese P. 2013. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci U S A 110:20248–20253. doi: 10.1073/pnas.1320524110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Visher E, Whitefield SE, McCrone JT, Fitzsimmons W, Lauring AS. 2016. The mutational robustness of influenza A virus. PLoS Pathog 12:e1005856. doi: 10.1371/journal.ppat.1005856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734–736. doi: 10.1126/science.1178258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Davidson I, Shkoda I, Golender N, Perk S, Lapin K, Khinich Y, Panshin A. 2013. Genetic characterization of HA gene of low pathogenic H9N2 influenza viruses isolated in Israel during 2006-2012 periods. Virus Genes 46:255–263. doi: 10.1007/s11262-012-0852-4. [DOI] [PubMed] [Google Scholar]
  • 52.Lee CW, Senne DA, Suarez DL. 2004. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 78:8372–8381. doi: 10.1128/JVI.78.15.8372-8381.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.DuBois RM, Zaraket H, Reddivari M, Heath RJ, White SW, Russell CJ. 2011. Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity. PLoS Pathog 7:e1002398. doi: 10.1371/journal.ppat.1002398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Reed ML, Bridges OA, Seiler P, Kim JK, Yen HL, Salomon R, Govorkova EA, Webster RG, Russell CJ. 2010. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol 84:1527–1535. doi: 10.1128/JVI.02069-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Herfst S, Imai M, Kawaoka Y, Fouchier RA. 2014. Avian influenza virus transmission to mammals. Curr Top Microbiol Immunol 385:137–155. doi: 10.1007/82_2014_387. [DOI] [PubMed] [Google Scholar]
  • 56.Lee DH, Fusaro A, Song CS, Suarez DL, Swayne DE. 2016. Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea. Virology 488:225–231. doi: 10.1016/j.virol.2015.11.023. [DOI] [PubMed] [Google Scholar]
  • 57.Yamada S, Hatta M, Staker BL, Watanabe S, Imai M, Shinya K, Sakai-Tagawa Y, Ito M, Ozawa M, Watanabe T, Sakabe S, Li C, Kim JH, Myler PJ, Phan I, Raymond A, Smith E, Stacy R, Nidom CA, Lank SM, Wiseman RW, Bimber BN, O'Connor DH, Neumann G, Stewart LJ, Kawaoka Y. 2010. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 6:e1001034. doi: 10.1371/journal.ppat.1001034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Iqbal M, Yaqub T, Reddy K, McCauley JW. 2009. Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One 4:e5788. doi: 10.1371/journal.pone.0005788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Zhang W, Shi Y, Lu X, Shu Y, Qi J, Gao GF. 2013. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science 340:1463–1467. doi: 10.1126/science.1236787. [DOI] [PubMed] [Google Scholar]
  • 60.Byrd-Leotis L, Galloway SE, Agbogu E, Steinhauer DA. 2015. Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes. J Virol 89:4504–4516. doi: 10.1128/JVI.00057-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Costa T, Chaves AJ, Valle R, Darji A, van Riel D, Kuiken T, Majo N, Ramis A. 2012. Distribution patterns of influenza virus receptors and viral attachment patterns in the respiratory and intestinal tracts of seven avian species. Vet Res 43:28. doi: 10.1186/1297-9716-43-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Kuchipudi SV, Nelli R, White GA, Bain M, Chang KC, Dunham S. 2009. Differences in influenza virus receptors in chickens and ducks: implications for interspecies transmission. J Mol Genet Med 3:143–151. doi: 10.4172/1747-0862.1000026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Siddique N, Rafique S, Abbas MA, Ali A, Rahim A, Naeem K. 2016. Genetic variability among the circulating avian influenza virus serotype H9N2 and its relationship with the vaccine failure in commercial poultry, abstr P-447 Abstr isirv Options IX Control Influenza, Chicago, IL, 24 to 28 August 2016. [Google Scholar]
  • 64.Daniels PS, Jeffries S, Yates P, Schild GC, Rogers GN, Paulson JC, Wharton SA, Douglas AR, Skehel JJ, Wiley DC. 1987. The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J 6:1459–1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Donis R, Busch J, McBride R, Paulson JC, Katz JM, Tumpey TM. 2008. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc Natl Acad Sci U S A 105:7558–7563. doi: 10.1073/pnas.0801259105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Belser JA, Lu X, Maines TR, Smith C, Li Y, Donis RO, Katz JM, Tumpey TM. 2007. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 81:11139–11147. doi: 10.1128/JVI.01235-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Centers for Disease Control and Prevention. 2004. Update: influenza activity—United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 53:547–552. [PubMed] [Google Scholar]
  • 68.Hennion RM, Hill G. 2015. The preparation of chicken kidney cell cultures for virus propagation. Methods Mol Biol 1282:57–62. doi: 10.1007/978-1-4939-2438-7_6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Hennion RM. 2015. The preparation of chicken tracheal organ cultures for virus isolation, propagation, and titration. Methods Mol Biol 1282:51–56. doi: 10.1007/978-1-4939-2438-7_5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113. doi: 10.1073/pnas.100133697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Webster R, Cox N, Stöhr K. 2002. WHO manual on animal influenza diagnosis and surveillance, 2nd ed World Health Organization, Geneva, Switzerland. [Google Scholar]
  • 72.Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL. 2002. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40:3256–3260. doi: 10.1128/JCM.40.9.3256-3260.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363–371. doi: 10.1038/nprot.2009.2. [DOI] [PubMed] [Google Scholar]
  • 74.Schrödinger LLC. 2010. The PyMOL molecular graphics system, version 1.3r1. Schrödinger LLC, New York, NY. [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES